{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:11:49Z","timestamp":1777518709028,"version":"3.51.4"},"reference-count":25,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.3892\/or.2017.5891","type":"journal-article","created":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T12:19:01Z","timestamp":1502194741000},"page":"2535-2542","source":"Crossref","is-referenced-by-count":13,"title":["Complex analysis of the TP53 tumor suppressor in mantle cell and diffuse large B-cell lymphomas"],"prefix":"10.3892","volume":"38","author":[{"given":"Lenka","family":"Zlamalikova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojmir","family":"Moulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbora","family":"Ravcukova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kvetoslava","family":"Liskova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitka","family":"Malcikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Salek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiri","family":"Jarkovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miluse","family":"Svitakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Hrabalkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Smarda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Smardova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,8,8]]},"reference":[{"key":"key20180107220207_b1-or-38-04-2535","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1038\/sj.onc.1208615","article-title":"The p53 pathway: Positive and negative feedback loops","volume":"24","author":"Harris","year":"2005","journal-title":"Oncogene"},{"key":"key20180107220207_b2-or-38-04-2535","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0092-8674(03)01075-4","article-title":"Principles of tumor suppression","volume":"116","author":"Sherr","year":"2004","journal-title":"Cell"},{"key":"key20180107220207_b3-or-38-04-2535","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1182\/blood-2011-11-366062","article-title":"Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies","volume":"119","author":"Xu-Monette","year":"2012","journal-title":"Blood"},{"key":"key20180107220207_b4-or-38-04-2535","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/humu.22552","article-title":"TP53 mutations in human cancer: Database reassessment and prospects for the next decade","volume":"35","author":"Leroy","year":"2014","journal-title":"Hum Mutat"},{"key":"key20180107220207_b5-or-38-04-2535","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"key20180107220207_b6-or-38-04-2535","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3324\/haematol.2015.134510","article-title":"European Research Initiative on CLL (ERIC) and the European Association for Haematopathology (EAHP): Clinical impact of recurrently mutated genes on lymphoma diagnostics: State-of-the-art and beyond","volume":"101","author":"Rosenquist","year":"2016","journal-title":"Haematologica"},{"key":"key20180107220207_b7-or-38-04-2535","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.blre.2015.08.002","article-title":"Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?","volume":"30","author":"Iqbal","year":"2016","journal-title":"Blood Rev"},{"key":"key20180107220207_b8-or-38-04-2535","first-page":"699","article-title":"Loss of the p53 tumor suppressor activity is associated with negative prognosis of mantle cell lymphoma","volume":"36","author":"Stefancikova","year":"2010","journal-title":"Int J Oncol"},{"key":"key20180107220207_b9-or-38-04-2535","first-page":"1413","article-title":"Prognostic impact of p53 aberrations for R-CHOP-treated patients with diffuse large B-cell lymphoma","volume":"39","author":"Stefancikova","year":"2011","journal-title":"Int J Oncol"},{"key":"key20180107220207_b10-or-38-04-2535","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1073\/pnas.92.9.3963","article-title":"A simple p53 functional assay for screening cell lines, blood, and tumors","volume":"92","author":"Flaman","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107220207_b11-or-38-04-2535","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000050597","article-title":"Rare somatic p53 mutation identified in breast cancer: A case report","volume":"22","author":"Smardov\u00e1","year":"2001","journal-title":"Tumour Biol"},{"key":"key20180107220207_b12-or-38-04-2535","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/ng1093-124","article-title":"Screening patients for heterozygous p53 mutations using a functional assay in yeast","volume":"5","author":"Ishioka","year":"1993","journal-title":"Nat Genet"},{"key":"key20180107220207_b13-or-38-04-2535","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.onc.1200812","article-title":"Field cancerisation and polyclonal p53 mutation in the upper aero-digestive tract","volume":"14","author":"Waridel","year":"1997","journal-title":"Oncogene"},{"key":"key20180107220207_b14-or-38-04-2535","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/humu.23035","article-title":"TP53 variations in human cancers: New lessons from the IARC TP53 database and genomics Data","volume":"37","author":"Bouaoun","year":"2016","journal-title":"Hum Mutat"},{"key":"key20180107220207_b15-or-38-04-2535","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/sj.onc.1210748","article-title":"Analysis of transactivation capability and conformation of p53 temperature-dependent mutants and their reactivation by amifostine in yeast","volume":"27","author":"Grochova","year":"2008","journal-title":"Oncogene"},{"key":"key20180107220207_b16-or-38-04-2535","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1038\/leu.2011.162","article-title":"Impact of TP53 mutation and 17p deletion in mantle cell lymphoma","volume":"25","author":"Halld\u00f3rsd\u00f3ttir","year":"2011","journal-title":"Leukemia"},{"key":"key20180107220207_b17-or-38-04-2535","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.3324\/haematol.2011.055715","article-title":"The impact of cyclin D1 mRNA isoforms, morphology and p53 in mantle cell lymphoma: p53 alterations and blastoid morphology are strong predictors of a high proliferation index","volume":"97","author":"Slotta-Huspenina","year":"2012","journal-title":"Haematologica"},{"key":"key20180107220207_b18-or-38-04-2535","doi-asserted-by":"crossref","first-page":"18250","DOI":"10.1073\/pnas.1314608110","article-title":"Landscape of somatic mutations and clonal evolution in mantle cell lymphoma","volume":"110","author":"Be\u00e0","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107220207_b19-or-38-04-2535","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1182\/blood-2013-01-478834","article-title":"The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma","volume":"121","author":"Meissner","year":"2013","journal-title":"Blood"},{"key":"key20180107220207_b20-or-38-04-2535","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1182\/blood-2013-07-517177","article-title":"The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells","volume":"123","author":"Zhang","year":"2014","journal-title":"Blood"},{"key":"key20180107220207_b21-or-38-04-2535","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/bjh.12854","article-title":"SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma: a Nordic Lymphoma Group study","volume":"166","author":"Nordstr\u00f6m","year":"2014","journal-title":"Br J Haematol"},{"key":"key20180107220207_b22-or-38-04-2535","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1182\/blood-2015-02-628792","article-title":"European Mantle Cell Lymphoma Network: High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma","volume":"126","author":"Delfau-Larue","year":"2015","journal-title":"Blood"},{"key":"key20180107220207_b23-or-38-04-2535","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12308-008-0008-6","article-title":"Genomic deletion and promoter methylation status of Hypermethylated in Cancer 1 (HIC1) in mantle cell lymphoma","volume":"1","author":"St\u00f6cklein","year":"2008","journal-title":"J Hematop"},{"key":"key20180107220207_b24-or-38-04-2535","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1182\/blood-2012-05-433334","article-title":"Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: Report from an International DLBCL Rituximab-CHOP Consortium Program Study","volume":"120","author":"Xu-Monette","year":"2012","journal-title":"Blood"},{"key":"key20180107220207_b25-or-38-04-2535","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.critrevonc.2015.08.006","article-title":"TP53 dysfunction in diffuse large B-cell lymphoma","volume":"97","author":"Lu","year":"2016","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T22:02:19Z","timestamp":1515362539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2017.5891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,8,8]]},"published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.3892\/or.2017.5891"],"URL":"https:\/\/doi.org\/10.3892\/or.2017.5891","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4]]}}}